Menchón JM - Search Results

1

[Neuroactivation of the Tower of Hanoi in patients with obsessive-compulsive disorder and healthy volunteers].

Fernández A, Pino Alonso M, Mataix-Cols D, Roca M, Vallejo J, Puchal R, Menchón JM, Martín-Comín J. Fernández A, et al. Among authors: menchon jm. Rev Esp Med Nucl. 2003 Nov;22(6):376-85. doi: 10.1016/s0212-6982(03)72221-6. Rev Esp Med Nucl. 2003. PMID: 14588230 Clinical Trial. Spanish.

2

Clomipramine versus phenelzine in obsessive-compulsive disorder. A controlled clinical trial.

Vallejo J, Olivares J, Marcos T, Bulbena A, Menchón JM. Vallejo J, et al. Among authors: menchon jm. Br J Psychiatry. 1992 Nov;161:665-70. doi: 10.1192/bjp.161.5.665. Br J Psychiatry. 1992. PMID: 1422616 Clinical Trial.

3

Predictors of antidepressant treatment outcome in melancholia: psychosocial, clinical and biological indicators.

Vallejo J, Gasto C, Catalan R, Bulbena A, Menchon JM. Vallejo J, et al. Among authors: menchon jm. J Affect Disord. 1991 Mar;21(3):151-62. doi: 10.1016/0165-0327(91)90036-r. J Affect Disord. 1991. PMID: 1829739 Clinical Trial.

4

Changes in platelet 3-H-imipramine binding: influences of protein concentration of varying proportions of cytosol or intact platelets and displacing agents used.

Rosel-Soria P, Vallejo J, Oros M, Serrallonga J, Menchon JM, Navarro MA. Rosel-Soria P, et al. Among authors: menchon jm. Biol Psychiatry. 1995 Oct 1;38(7):464-70. doi: 10.1016/0006-3223(94)00380-l. Biol Psychiatry. 1995. PMID: 8672607

5

Growth hormone response to growth hormone releasing hormone in non-delusional and delusional depression and healthy controls.

Contreras F, Navarro MA, Menchon JM, Rosel P, Serrallonga J, Perez-Arnau F, Urretavizcaya M, Vallejo J. Contreras F, et al. Among authors: menchon jm. Psychol Med. 1996 Mar;26(2):301-7. doi: 10.1017/s0033291700034693. Psychol Med. 1996. PMID: 8685286

6

Seasonal variability in blood platelet 3H-imipramine binding in healthy controls: age and gender effects.

Soria PR, Vallejo J, Oros M, Menchon JM, Cortadellas T, Navarro MA, Urretavizcaya M. Soria PR, et al. Among authors: menchon jm. Biol Psychiatry. 1996 Nov 15;40(10):981-5. doi: 10.1016/0006-3223(95)00593-5. Biol Psychiatry. 1996. PMID: 8915556

7

Regional distribution of specific high affinity binding sites for 3H-imipramine and 3H-paroxetine in human brain.

Rosel P, Menchon JM, Oros M, Vallejo J, Cortadellas T, Arranz B, Alvarez P, Navarro MA. Rosel P, et al. Among authors: menchon jm. J Neural Transm (Vienna). 1997;104(1):89-96. doi: 10.1007/BF01271297. J Neural Transm (Vienna). 1997. PMID: 9085196

8

Platelet [3H]imipramine and [3H]paroxetine binding in depressed patients.

Rosel P, Menchón JM, Vallejo J, Arranz B, Navarro MA, Lirón F, Alvarez P. Rosel P, et al. Among authors: menchon jm. J Affect Disord. 1997 Jun;44(1):79-85. doi: 10.1016/s0165-0327(97)00033-5. J Affect Disord. 1997. PMID: 9186805

9

High affinity [3H]imipramine and [3H]paroxetine binding sites in suicide brains.

Rosel P, Arranz B, Vallejo J, Oros M, Menchón JM, Alvarez P, Navarro MA. Rosel P, et al. Among authors: menchon jm. J Neural Transm (Vienna). 1997;104(8-9):921-9. doi: 10.1007/BF01285560. J Neural Transm (Vienna). 1997. PMID: 9451724

10

Variations in [3H]imipramine and 5-HT2A but not [3H]paroxetine binding sites in suicide brains.

Rosel P, Arranz B, Vallejo J, Oros M, Crespo JM, Menchon JM, Navarro MA. Rosel P, et al. Among authors: menchon jm. Psychiatry Res. 1998 Jun 30;82(3):161-70. doi: 10.1016/s0925-4927(98)00015-8. Psychiatry Res. 1998. PMID: 9754440

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

445 results

Search Page

Filters